Source: Annual Congress 2004 - Immunology in pulmonary diseases
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Pourpak, A. Aghamohammadi, A. Farhoudi, M. Gharagozlou, M. Moin, M. Movahedi, Z. Chavoshzadeh, L. Jadid, N. Rezaei (Tehran, Iran). Efficacy of intravenous immunoglobulin therapy on the incidence of pneumonia in Iranian patients with common variable immunodeficiency. Eur Respir J 2004; 24: Suppl. 48, 2238

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary complications in intravenous drug users with and without human immunodeficiency virus co-infection. Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019 Outcomes in a cohort of childhood chronic cough: raised incidence of primary immunodeficiency Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans Year: 2019 Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients Source: Eur Respir J 2015; 45: 463-472 Year: 2015 Respiratory impact and quality of life in patients with common variable immunodeficiency receiving subcutaneous IgG replacement therapy Source: Annual Congress 2007 - Diagnostic tests and treatment in non cystic fibrosis bronchiectasis Year: 2007 Efficacy of α-tocoferol in the treatment of patients with pneumonia Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Hospital-acquired pneumonia in patients receiving immunosuppressive therapy Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Prophylaxis with azithromycin in primary immunodeficiency and bronchiectasis Source: Annual Congress 2005 - New insights in respiratory infections in children Year: 2005 Efficacy and safety of stepwise therapy in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 377s Year: 2006 Evaluation of efficacy of interferon inducer in treatment of the recurrent acute respiratory viral infections in children Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Prevalence of virus infections in patients with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 599s Year: 2004 Prevalence of oral corticosteroid use in the German severe asthma population Source: ERJ Open Res, 5 (4) 00092-2019; 10.1183/23120541.00092-2019 Year: 2019 Intravenous immunoglobulin in community acquired pneumonia Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011 Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia Source: Eur Respir J 2015; 45: 1624-1631 Year: 2015 How often can we use short course therapy in patients with hospital-acquired pneumonia? Source: Eur Respir J 2007; 30: Suppl. 51, 408s Year: 2007 Adjunctive systemic corticosteroid treatment in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP Source: Eur Respir J 2013; 41: 123-130 Year: 2013 Efficacy of isoniazid preventive therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders-a retrospective cohort study in Taiwan Source: International Congress 2017 – Migrants and screening Year: 2017 Switch from intravenous to oral antibiotic therapy in hospitalized patients with non-severe community acquired pneumonia Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections Year: 2010 Therapeutic regimens in community acquired pneumonia (CAP): association with patients characteristics and outcomes Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Features of intravenous anti TB therapy in patients with first diagnosed pulmonary TB in the intensive phase of treatment Source: International Congress 2017 – MDRTB: detection and management Year: 2017